Dilution of Share Value from Stock Options
First written in FY2017. 17 of 22 entries say "Materialised", first in FY2019-Q1. Latest entry: FY2026-H1.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026-H1MaterialisedAnnual report
「Date of resolution 26 February 2026 Category and number of grantees (people) Directors of the company 2 Employees of the company 1 Number of stock acquisition rights (units)* 85 Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 8,500」
Based on the resolution dated 26 February 2026, the company issued 85 stock acquisition rights to 2 directors and 1 employee, equivalent to 8,500 common shares, adding a potential dilution factor. - FY2025MaterialisedAnnual report
「Number of stock acquisition rights (units)* 1,200 Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 120,000」
Under the resolution dated 10 December 2025, the company issued stock acquisition rights equivalent to 120,000 shares to 31 employees, adding a potential dilution factor. The voluntary relinquishment of existing stock acquisition rights equivalent to 81,000 shares was also disclosed. - FY2025-H1MaterialisedAnnual report
「The stock acquisition rights issued during the six-month accounting period under review were as follows. Date of resolution 22 January 2025 Category and number of grantees (people) Directors of the company 1 Employees of the company 9 Number of stock acquisition rights (units)* 245 Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 24,500」
On 28 February 2025, the company issued 245 stock acquisition rights to 1 director and 9 employees, equivalent to 24,500 common shares, adding a potential dilution factor. - FY2024MaterialisedAnnual report
「As of the end of the month preceding the date of submission of this document, the number of potential shares related to stock acquisition rights was 106,090, equivalent to 3.80% of the total 2,795,041 shares issued.」
During the fiscal year, 4,350 shares were issued through the exercise of stock acquisition rights. Potential shares totaled 106,090, equivalent to 3.80% of total shares issued, and the dilution factor continues to materialize. - FY2024-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
During the first quarter, the total number of shares issued increased by 1,350 through the exercise of stock acquisition rights. The company also disclosed 245 stock acquisition rights issued on 27 February 2024, equivalent to 24,500 common shares. - FY2023MaterialisedAnnual report
「As of the end of the month preceding the date of submission of this document, the number of potential shares related to stock acquisition rights was 117,990, equivalent to 4.23% of the total 2,790,691 shares issued.」
During the fiscal year, 48,000 shares were issued through the exercise of stock acquisition rights, leaving potential shares equivalent to 4.23%. Dilution factors continue to materialize. - FY2023-Q2MaterialisedAnnual report
「1 March 2023–31 May 2023 16,000 2,773,691 5,440 754,683 5,440 747,683」
The number of shares increased by 16,000 during the second quarter through the exercise of stock acquisition rights, increasing capital and capital reserves by ¥5.44 million each. Dilution factors continue to materialize. - FY2023-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
15,000 shares were issued in the first quarter through the exercise of stock acquisition rights, meaning that some potential dilution factors have actually materialised. - FY2022-Q3MaterialisedAnnual report
「From 1 September 2022 to 30 September 2022, the total number of issued shares increased by 10,000 through the exercise of stock acquisition rights.」
Stock acquisition rights were exercised after the end of the third-quarter accounting period, increasing the number of issued shares by 10,000. Potential dilution factors continue to materialise. - FY2022-Q2MaterialisedAnnual report
「1 September 2022–31 May 2022 35,000 2,667,691 18,865 703,718 18,865 696,718」
Through the exercise of stock acquisition rights, 35,000 shares were added from March to May 2022, and capital stock and capital surplus each increased by ¥18.865 million. Some potential dilution factors continue to materialise. - FY2021MitigatedAnnual report
「As of the end of the month preceding the date of filing this document, the number of potential shares related to stock acquisition rights was 257,850, equivalent to 9.79% of the 2,632,691 issued shares.」
Of the 410,000 shares underlying the third series of stock acquisition rights, 300,000 were exercised during the period, reducing the potential-share ratio as of the end of the month preceding the filing date from 18.1% in the previous disclosure to 9.79%. - FY2021-Q3WorsenedAnnual report
「The total number of shares underlying these stock acquisition rights is 410,000 common shares (18.1% of the company's total issued shares of 2,262,691 as of 16 July 2021).」
In addition to issuing 70,000 shares through a third-party allotment, the company issued the third series of stock acquisition rights underlying 410,000 common shares. Through the exercise of the stock acquisition rights, 10,000 shares were issued in September 2021 and 50,000 shares from 1 September to 12 October 2021, increasing the potential dilution factor. - FY2021-Q1MaterialisedAnnual report
「Through the exercise of stock acquisition rights, capital stock and capital surplus each increased by ¥4.420 million.」
Stock acquisition rights were exercised during the cumulative first-quarter period, increasing the number of issued shares by 13,000 and capital stock and capital surplus by ¥4.420 million each. - FY2020MaterialisedAnnual report
「As of the end of the month preceding the date of filing this document, the number of potential shares related to stock acquisition rights was 88,810, equivalent to 3.92% of the 2,262,691 issued shares.」
Share issuance through the exercise of stock acquisition rights continued, with 13,000 shares added from December 2020 to January 2021. The proportion of potential shares declined from 4.69% to 3.92%. - FY2020-Q1MaterialisedAnnual report
「1 December 2019–29 February 2020 27,490 2,249,691 9,711 481,248 9,711 474,248」
Through the exercise of stock acquisition rights, the number of issued shares increased by 27,490 during the cumulative first-quarter period, while capital stock and capital surplus each increased by ¥9.711 million. Potential dilution factors continue to materialise. - FY2019MaterialisedAnnual report
「From 1 December 2019 to 31 January 2020, the total number of issued shares increased by 27,490 through the exercise of stock acquisition rights.」
Shares were issued through the exercise of stock acquisition rights during the year and before filing. As of the end of the month preceding the filing date, potential shares numbered 105,560, representing 4.69% of the total number of issued shares. - FY2019-Q3MaterialisedAnnual report
「In addition, through the exercise of stock acquisition rights, capital stock and capital surplus each increased by ¥9.718 million during the cumulative third-quarter period.」
Stock acquisition rights were also exercised during the cumulative third-quarter period, increasing capital stock and capital surplus by ¥9.718 million each. - FY2019-Q2MaterialisedAnnual report
「In addition, through the exercise of stock acquisition rights, capital stock and capital surplus each increased by ¥7.618 million during the cumulative second-quarter period.」
Stock acquisition rights were exercised during the cumulative second-quarter period, increasing capital stock and capital surplus by ¥7.618 million each. - FY2019-Q1MaterialisedAnnual report
「From 1 March 2019 to 31 March 2019, the number of issued shares increased by 10,310 through the exercise of stock acquisition rights.」
The company states that the number of issued shares actually increased through the exercise of stock acquisition rights, meaning that some potential dilution factors have materialised. - FY2018RestatedAnnual report
「As of the date of filing this document, the number of potential shares related to stock acquisition rights was 159,510, equivalent to 7.29% of the 2,187,641 issued shares.」
The company continues to quantify potential dilution from stock options. It also indicates a policy of continuing to use incentive schemes, including stock options. - FY2018-Q3RestatedAnnual report
「Increase in common shares (shares) 121,215 (of which stock acquisition rights (shares)) (121,215)」
In calculating diluted earnings per share, the company discloses an increase of 121,215 common shares resulting from stock acquisition rights. It continues to quantify the potential dilution risk from stock options. - FY2017First statedAnnual report
「As of the date of filing this document, the number of potential shares related to stock acquisition rights was 166,160, equivalent to 7.86% of the 2,112,941 issued shares.」
The company quantifies the potential dilution resulting from the exercise of stock options for officers and employees.